Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Personalis, Inc.NASDAQ: PSNL
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$27.6M, compared with -$13.13M a year earlier. Trailing-twelve-month EBITDA was -$85.53M.
Context
- EBITDA grew in size in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of -$87.55M (-23.3%) for the fiscal year ending Dec 2026, a slowdown from the -1.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$27.6M-29.7% QoQ
- Last fiscal yearDec 2025
- -$71M-1.0% YoY
- LTMMar 2026
- -$85.53M-16.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -110.2% | -47.5% | +62.7 pp |
| 1 year | -1.0% | -23.3% | -22.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (71M) USD
- Year-over-year change
- -1.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (71M) | -1.0% |
| FY2024 | 2024-12-31 | (70.3M) | +27.4% |
| FY2023 | 2023-12-31 | (96.81M) | +7.5% |
| FY2022 | 2022-12-31 | (104.64M) | -77.3% |
| FY2021 | 2021-12-31 | (59.01M) | — |
EBITDA vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's LTM Mar 2026 EBITDA of -$85.53M is the 6th highest of the 10 companies compared; the peer median is -$76.43M.
- Its year-over-year change of -16.7% is the 6th highest of 10, against a peer median of +10.8%.
- EBITDA amounts to 132.6% of revenue for PSNL, versus a peer median of 18.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $129.77M | +184.0% | — | 23.1% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $50.25M | +362.6% | — | 12.6% |
| LTM Jun 2026 | $12.89M | +145.3% | — | 1.7% | |
| LTM Mar 2026 | -$58.51M | -133.4% | — | 18.3% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | -$76.43M | -374.1% | — | 16.8% |
| LTM Mar 2026 | -$85.53M | -16.7% | — | 132.6% | |
| LTM Jun 2026 | -$178.71M | +15.6% | — | 6.6% | |
| LTM Mar 2026 | -$334.2M | -423.0% | — | 40.3% | |
| LTM Jun 2026 | -$374.1M | +10.8% | — | 226.4% | |
| LTM Sep 2026 | -$441.45M | -24.7% | — | 34.5% | |
| Peer median (excluding PSNL) | -$76.43M | +10.8% | — | 18.3% | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 85.49M | 65.05M | 73.48M | 84.61M | 0 |
| Cost of Revenue | 53.84M | 51.7M | 55.27M | 57.79M | 53.87M |
| Gross Profit | 31.66M | 13.35M | 18.21M | 26.83M | (53.87M) |
| Gross Margin | 37.0% | 20.5% | 24.8% | 31.7% | — |
| Research & Development | 49.31M | 64.91M | 64.78M | 48.91M | 50.26M |
| Selling, General & Admin | 47.7M | 63.97M | 49.73M | 46.19M | 53.57M |
| Operating Expenses | 97.01M | 128.88M | 128.14M | 95.09M | 34.19M |
| Depreciation & Amortization | 6.01M | 8.43M | 11.3M | 10.94M | 10.05M |
| EBITDA | (59.01M) | (104.64M) | (96.81M) | (70.3M) | (71M) |
| EBITDA Margin | -69.0% | -160.9% | -131.7% | -83.1% | — |
| Operating Income | (65.35M) | (115.53M) | (109.94M) | (68.27M) | (88.06M) |
| Operating Margin | -76.4% | -177.6% | -149.6% | -80.7% | — |
| Interest Income | 367K | 2.4M | 5.9M | 5.51M | 7.16M |
| Interest Expense | 184K | 201K | 110K | 24K | 205K |
| Other Income / Expenses | 141K | 2.26M | 1.72M | (13M) | 6.81M |
| Income Before Tax | (65.21M) | (113.28M) | (108.21M) | (81.27M) | (81.25M) |
| Pre-Tax Margin | -76.3% | -174.1% | -147.3% | -96.0% | — |
| Income Tax Expense | 14K | 40K | 83K | 18K | 21K |
| Net Income | (65.23M) | (113.32M) | (108.3M) | (81.28M) | (81.27M) |
| Net Margin | -76.3% | -174.2% | -147.4% | -96.1% | — |
| EPS (Basic) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| EPS (Diluted) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| Weighted Avg Shares | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
| Weighted Avg Shares (Diluted) | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.